Atlas Trials

Alfentanil Versus Remifentanil in Patient-controlled Sedation During Endoscopic Retrograde Cholangiopancreatography (ERCP)

Clinical trial NCT01350037 · COMPLETED

Trial details

NCT number
NCT01350037
Sponsor
Helsinki University Central Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Biliary Tract DiseasesPancreatic Diseases
Start date
2009-06-01
Primary completion
2009-09-01
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.